Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruiting Guo

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Chinese Medical Journal|December 10, 2024
Granulocyte colony-stimulating factor in neutropenia management after CAR-T cell therapy: A safety and efficacy evaluation in refractory/relapsed B-cell acute lymphoblastic leukemiaXinping Cao, Meng Zhang, Ruiting Guo, et al.
The Journal of Infectious Diseases|February 22, 2024
Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older AdultsChristine A Shaw, Brandon Essink, Charles Harper, et al.
Respiratory Investigation|September 10, 2024
Safety and immunogenicity of an mRNA-based RSV vaccine in Japanese older adults aged ≥60 years: A phase 1, randomized, observer-blind, placebo-controlled trialDavid Fitz-Patrick, Hanako Mihara, Anthony Mills, et al.
Human Vaccines & Immunotherapeutics|February 2, 2026
Phase 1/2 randomized, observer-blind clinical trial of a first-generation, mRNA-based vaccine against seasonal influenza and COVID-19 in healthy adultsAmanda K Rudman Spergel, Carole Henry, Raffael Nachbagauer, et al.
The New England Journal of Medicine|December 10, 2021
Betibeglogene Autotemcel Gene Therapy for Non-β<sup>0</sup>/β<sup>0</sup> Genotype β-ThalassemiaFranco Locatelli, Alexis A Thompson, Janet L Kwiatkowski, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Chinese Medical Journal|December 10, 2024
Granulocyte colony-stimulating factor in neutropenia management after CAR-T cell therapy: A safety and efficacy evaluation in refractory/relapsed B-cell acute lymphoblastic leukemiaXinping Cao, Meng Zhang, Ruiting Guo, et al.
The Journal of Infectious Diseases|February 22, 2024
Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older AdultsChristine A Shaw, Brandon Essink, Charles Harper, et al.
Respiratory Investigation|September 10, 2024
Safety and immunogenicity of an mRNA-based RSV vaccine in Japanese older adults aged ≥60 years: A phase 1, randomized, observer-blind, placebo-controlled trialDavid Fitz-Patrick, Hanako Mihara, Anthony Mills, et al.
Human Vaccines & Immunotherapeutics|February 2, 2026
Phase 1/2 randomized, observer-blind clinical trial of a first-generation, mRNA-based vaccine against seasonal influenza and COVID-19 in healthy adultsAmanda K Rudman Spergel, Carole Henry, Raffael Nachbagauer, et al.
The New England Journal of Medicine|December 10, 2021
Betibeglogene Autotemcel Gene Therapy for Non-β<sup>0</sup>/β<sup>0</sup> Genotype β-ThalassemiaFranco Locatelli, Alexis A Thompson, Janet L Kwiatkowski, et al.
Pageof 5